Cardiovascular morbidity in obstructive sleep apnoea

S. Andreas (Immenhausen, Germany)

Source: Annual Congress 2009 - PG5 Core Curriculum Postgraduate Course: Obstructive sleep apnoea – current pathophysiological, clinical and therapeutic concepts
Disease area: Sleep and breathing disorders

Slide presentationPDF journal article, handout or slidesMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Andreas (Immenhausen, Germany). Cardiovascular morbidity in obstructive sleep apnoea. Annual Congress 2009 - PG5 Core Curriculum Postgraduate Course: Obstructive sleep apnoea – current pathophysiological, clinical and therapeutic concepts

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cardiovascular morbidity and obstructive sleep apnoea in children
Source: Annual Congress 2009 - Current developments in sleep-disordered breathing in children
Year: 2009


Cardiovascular and metabolic consequences of obstructive sleep apnoea
Source: Eur Respir J 2001; 18: Suppl. 33, 519s
Year: 2001

Obstructive sleep apnea and specific cardiovascular outcomes
Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care
Year: 2018

Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease
Source: Eur Respir J 2013; 41: 616-620
Year: 2013



Obstructive sleep apnoea and COPD
Source: Eur Respir Mon 2013; 59: 135-143
Year: 2013


Hypertension and obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006


Cardiovascular comorbidity by clinical phenotypes of obstructive sleep apnea and sleeping hours
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020


Risk factors of hypercapnia in patient with obstructive sleep apnea
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012


Obstructive sleep apnoea and cardiovascular events in a Chinese cohort
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018

Comorbidities of obstructive sleep apnoea syndrome
Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Year: 2011


Obstructive sleep apnoea and heart failure
Source: International Congress 2016 – PG18 Sleep apnoea and comorbidities
Year: 2016

Clinical assessment of obstructive sleep apnoea
Source: Annual Congress 2009 - PG5 Core Curriculum Postgraduate Course: Obstructive sleep apnoea – current pathophysiological, clinical and therapeutic concepts
Year: 2009

Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Albuminuria in children with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011


Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008


Predictors of hypercapnia in obstructive sleep apnoea (OSA)
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Year: 2010

Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients
Source: Eur Respir J 2008; 31: 223-225
Year: 2008